Latest Grant Funding News

EMVision Medical Devices has expanded its pivotal clinical trial sites, secured a $3 million government grant, and raised $14 million through placement and share purchase plan, positioning itself strongly for upcoming regulatory submissions and commercialisation.

Metal Bank Limited has completed phase one drilling at the Whiteheads Gold Project and secured major shareholder support for its acquisition of Hastings Technology Metals' gold assets, marking a significant step toward gold production in Western Australia.

Delorean Corporation has received a $2.7 million milestone payment from ARENA, advancing its SA1 Salisbury bioenergy facility toward renewable gas production underpinned by a key offtake deal with Origin Energy.

Australian Vanadium Limited has received a $4.9 million milestone payment from the federal government, advancing its integrated vanadium project aimed at supporting domestic battery energy storage solutions.

Lithium Universe Limited and Macquarie University have jointly applied for a $386,000 grant to develop a cutting-edge solar panel recycling pilot that could transform resource recovery and sustainability in Australia’s clean energy sector.

Vulcan Energy has obtained the crucial permit to build and operate its Central Lithium Plant in Frankfurt, marking a significant milestone in Europe's push for sustainable, domestic lithium production to support electric vehicle battery manufacturing.

Livium Ltd has inked a term sheet with the University of Melbourne to exclusively commercialise innovative microwave technology for rare earth elements extraction, promising high recovery rates and major energy savings.

Optiscan Imaging Limited reported a 17.6% revenue decline and a 4.1% increase in net loss for FY25, driven by lower orders and higher R&D spending. The company unveiled two new medical imaging devices as it ramps up commercial efforts.

First Graphene Limited reported a 13% reduction in net loss for FY25 alongside steady revenue and expanding commercial demand for its PureGRAPH products.

Calix Limited reported a 17% rise in product and services revenue for FY25, driven by its Magnesia and Leilac businesses, alongside a 23% reduction in operating expenses. The company extended its cash runway to 18 months, supported by a $21 million equity raise, while progressing key decarbonisation projects.

Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.

Carnegie Clean Energy reported a $2.33 million net loss for FY2025 but made significant strides in commercialising its wave energy technologies, supported by new loans and a US subsidiary launch.